<?xml version="1.0" encoding="UTF-8"?>
<ref id="B21-vaccines-07-00070">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gerna</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Zavattoni</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Baldanti</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Sarasini</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Chezzi</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Grossi</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Revello</surname>
    <given-names>M.G.</given-names>
   </name>
  </person-group>
  <article-title>Human cytomegalovirus (HCMV) leukoDNAemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection</article-title>
  <source>Transplantation</source>
  <year>1998</year>
  <volume>65</volume>
  <fpage>1378</fpage>
  <lpage>1385</lpage>
  <pub-id pub-id-type="doi">10.1097/00007890-199805270-00016</pub-id>
  <?supplied-pmid 9625022?>
  <pub-id pub-id-type="pmid">9625022</pub-id>
 </element-citation>
</ref>
